Science Explorer Back to mapMap
Discussion
Company · Aurora · United States

MBC Pharma (United States)

mbcpharma.comROR OpenAlex
Research works
12
▼ 77% vs 2018-21
Citations
207
16.6 per fractional work
Top-10% rate
7.0%
all institutions 10.0%
Open access
41%
world 40%
International
21%
world 18%
MBC Pharma (United States)

Not ranked overall: MBC Pharma (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does MBC Pharma (United States) work in?

In all years, 63% of research at MBC Pharma (United States) is in Health Sciences, 23% in Life Sciences. Its largest fields are Medicine (63%), Biochemistry, Genetics and Molecular Biology (21%), Social Sciences (8%). It does 1.8× the world's share of Health Sciences.

Health Sciences: 8 fractional works · 63.5% of its workMedicine: 8 fractional works · 62.6% of its workOncology: 2 fractional works · 16.9% of its workPhysiology: 1 fractional works · 7.9% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 6.8% of its workHematology: 1 fractional works · 6.4% of its workPulmonary and Respiratory Medicine: 1 fractional works · 6.3% of its workOrthopedics and Sports Medicine: 1 fractional works · 4.4% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 2.2% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 2.0% of its workEpidemiology: 0 fractional works · 1.8% of its workGenetics: 0 fractional works · 1.8% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 1.4% of its workNephrology: 0 fractional works · 1.4% of its workComplementary and alternative medicine: 0 fractional works · 0.6% of its workNeurology: 0 fractional works · 0.6% of its workSurgery: 0 fractional works · 0.6% of its workPharmacology: 0 fractional works · 0.6% of its workInfectious Diseases: 0 fractional works · 0.3% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.3% of its workHealth Professions: 0 fractional works · 0.9% of its workGeneral Health Professions: 0 fractional works · 0.9% of its workLife Sciences: 3 fractional works · 23.1% of its workBiochemistry, Genetics and Molecular Biology: 3 fractional works · 21.4% of its workMolecular Biology: 1 fractional works · 12.0% of its workGenetics: 0 fractional works · 3.9% of its workCancer Research: 0 fractional works · 3.4% of its workCell Biology: 0 fractional works · 1.7% of its workBiophysics: 0 fractional works · 0.5% of its workImmunology and Microbiology: 0 fractional works · 0.8% of its workApplied Microbiology and Biotechnology: 0 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.6% of its workToxicology: 0 fractional works · 0.6% of its workAgricultural and Biological Sciences: 0 fractional works · 0.4% of its workPlant Science: 0 fractional works · 0.4% of its workSocial Sciences: 1 fractional works · 10.3% of its workSocial Sciences: 1 fractional works · 8.4% of its workEducation: 1 fractional works · 8.0% of its workHealth: 0 fractional works · 0.3% of its workPsychology: 0 fractional works · 1.8% of its workApplied Psychology: 0 fractional works · 0.9% of its workSocial Psychology: 0 fractional works · 0.9% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.2% of its workPhysical Sciences: 0 fractional works · 3.1% of its workChemistry: 0 fractional works · 2.0% of its workOrganic Chemistry: 0 fractional works · 2.0% of its workMaterials Science: 0 fractional works · 0.6% of its workMaterials Chemistry: 0 fractional works · 0.6% of its workEngineering: 0 fractional works · 0.5% of its workBiomedical Engineering: 0 fractional works · 0.5% of its workALL ITS WORKMBC Pharma(United States)12fractional works, all years
Life Sciences23%Physical Sciences3%Health Sciences63%Social Sciences10%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 12 fields, with their numbers
    1. Medicine862.6%
    2. Health Professions00.9%
    1. Biochemistry, Genetics and Molecular Biology321.4%
    2. Immunology and Microbiology00.8%
    3. Pharmacology, Toxicology and Pharmaceutics00.6%
    4. Agricultural and Biological Sciences00.4%
    1. Social Sciences18.4%
    2. Psychology01.8%
    3. Economics, Econometrics and Finance00.2%
    1. Chemistry02.0%
    2. Materials Science00.6%
    3. Engineering00.5%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Who are the top researchers at MBC Pharma (United States)?

Ranked on the quality score, Shawn Patrick Zinnen and Alexander M. Karpeisky lead among researchers whose main affiliation is MBC Pharma (United States).

  1. 1 Shawn Patrick Zinnen United States · #1,383,903 worldwide 2.5k citations · 27 works
  2. 2 Alexander M. Karpeisky United States · #3,146,066 worldwide 1.4k citations · 46 works
All ranked researchers at MBC Pharma (United States)

What are the most cited papers from MBC Pharma (United States)?

The most cited paper from MBC Pharma (United States) is "Bisphosphonate conjugation for bone specific drug targeting" (Kristen B. Farrell, Alexander M. Karpeisky, Douglas H. Thamm et al., 2018), with 183 citations. Next come "The promise of Immuno-oncology: implications for defining the value of cancer treatment" (115) and "Colorado Medical Students’ Attitudes and Beliefs About Marijuana" (81).

Most cited papers
#PaperReleasedCitations
1 Bisphosphonate conjugation for bone specific drug targeting Kristen B. Farrell, Alexander M. Karpeisky, Douglas H. Thamm et al. · Bone Reports Open access 2 Jul 2018 183
2 The promise of Immuno-oncology: implications for defining the value of cancer treatment Howard L. Kaufman, Michael B. Atkins, Prasun Subedi et al. · Journal for ImmunoTherapy of Cancer Open access 17 May 2019 115
3 Colorado Medical Students’ Attitudes and Beliefs About Marijuana Michael Chan, Christopher E. Knoepke, Madeline L. Cole et al. · Journal of General Internal Medicine Open access 17 Jan 2017 81
4 Phase 1 Single‐ and Multiple‐Ascending‐Dose Randomized Studies of the Safety, Pharmacokinetics, and Pharmacodynamics of AG‐348, a First‐in‐Class Allosteric Activator of Pyruvate Kinase R, in Healthy Volunteers Hua Qiang Yang, Elizabeth Merica, Yue Chen et al. · Clinical Pharmacology in Drug Development 9 Aug 2018 57
5 A promising approach for treatment of tumor-induced bone diseases: Utilizing bisphosphonate derivatives of nucleoside antimetabolites Monica Madden Reinholz et al. · Bone Open access 16 Mar 2010 40
All 26 most cited papers, with filters and sorting

Which research topics does MBC Pharma (United States) publish most on?

By volume in 2022-now: Diabetes Management and Education, Chronic Disease Management Strategies, Cardiovascular Health and Risk Factors and Antibiotic Use and Resistance.

Diabetes Management and …0Diabetes Management and Education: 0 fractional worksChronic Disease Manageme…0Chronic Disease Management Strategies: 0 fractional worksCardiovascular Health an…0Cardiovascular Health and Risk Factors: 0 fractional worksAntibiotic Use and Resis…0Antibiotic Use and Resistance: 0 fractional worksBone health and treatments: 0 fractional worksSarcoma Diagnosis and Treatment: 0 fractional worksAsthma and respiratory d…0Asthma and respiratory diseases: 0 fractional worksAlkaline Phosphatase Research Studies: 0 fractional worksMobile Health and mHealth Applications: 0 fractional worksDigital Mental Health In…0Digital Mental Health Interventions: 0 fractional works
Endocrinology, Diabetes and MetabolismEpidemiologyCardiology and Cardiovascular MedicineApplied Microbiology and Biotechnology5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Diabetes Management and Education Endocrinology, Diabetes and Metabolism 0 works
  2. 2 Chronic Disease Management Strategies Epidemiology 0 works
  3. 3 Cardiovascular Health and Risk Factors Cardiology and Cardiovascular Medicine 0 works
  4. 4 Antibiotic Use and Resistance Applied Microbiology and Biotechnology 0 works
  5. 5 Bone health and treatments Oncology 0 works
  6. 6 Sarcoma Diagnosis and Treatment Pulmonary and Respiratory Medicine 0 works
  7. 7 Asthma and respiratory diseases Physiology 0 works
  8. 8 Alkaline Phosphatase Research Studies Endocrinology, Diabetes and Metabolism 0 works
  9. 9 Mobile Health and mHealth Applications General Health Professions 0 works
  10. 10 Digital Mental Health Interventions Applied Psychology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available40.9%not open59.1%

World: 40% of research is openly available.

with international co-authors21.2%domestic only78.8%

World: 18% is written across borders.

How has MBC Pharma (United States)'s research output changed?

Output in 2022-2025 was 77% lower than in 2018-2021.

still counting20052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is MBC Pharma (United States) as a percentage of every work published that year, 0.0000045% in 2024.

still counting0.000050%0.00010%MBC Pharma (United States)0.0000056% in 202520102020

Fractional works of MBC Pharma (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Aurora

All research institutions in Aurora

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about MBC Pharma (United States). Posts are plain text and can be reported.